Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Opexa Therapeutics reports third quarter 2013 financial results and provides corporate update
Functioning assessment vs. conventional medical assessment: a comparative study on health professionals' clinical decision-making and the fit with patient's own perspective of health.
In-home measurement of the effect of strategically weighted vests on ambulation.
Everyday memory impairment, neuroradiological findings and physical disability in multiple sclerosis.
Il-17 And Glutamte Excitotoxicity In The Pathogenesis Of Multiple Sclerosis.
Tackling autoimmunity with gene therapy.
Botulinum Toxin Injection Techniques for Management of Adult Spasticity.
Morning serum melatonin values in multiple sclerosis: A biochemical evaluation.
Interferon Beta and vitamin d synergize to induce immunoregulatory receptors on peripheral blood monocytes of multiple sclerosis patients.
Confronting Patients About Insufficient Effort: The Impact on Subsequent Symptom Validity and Memory Performance.
[Clinical features and prognosis of pediatric multiple sclerosis].
Utilization of the Expanded Disability Status Scale as a distinctive instrument for walking impairment in persons with multiple sclerosis with mild disability.
The Volume Activated Potassium Channel KCNK5 is Up-Regulated in Activated Human T Cells, but Volume Regulation is Impaired.
Treatment of optic neuritis with erythropoietin (TONE): a randomised, double-blind, placebo-controlled trial-study protocol.
Sphingosine 1-phosphate receptor 1 agonists: a patent review (2013-2015).
Orthognathic Surgery in a Patient with Multiple Sclerosis.
Association Between Urinary Symptoms and Urinary Tract Infection in Patients With Multiple Sclerosis.
Seasonal vitamin D changes and the impact on health risk assessment.
Defining Quality of Life Levels to Enhance Clinical Interpretation in Multiple Sclerosis: Application of a Novel Clustering Method.
The impact of neuromyelitis optica on the recognition of emotional facial expressions: A preliminary report.
[New aspects in the therapy of multiple sclerosis and optic neuritis.]
Individualized rituximab treatment for relapsing neuromyelitis optica: a pediatric case report.
Interactions and tradeoffs between cell recruitment, proliferation, and differentiation affect CNS regeneration.
Transient hyperCKemia in the setting of neuromyelitis optica (NMO).
The membrane attack complex of complement causes severe demyelination associated with acute axonal injury.
Pages
« first
‹ previous
…
384
385
386
387
388
389
390
391
392
…
next ›
last »